Pharmaceutical & Biotech News and Insights

AstraZeneca Photo-sharing Campaign to Help Fight Breast Cancer
October is Breast cancer awareness month. Yearly recognition of the deadly disease began in 1985 when drug manufacturer AstraZeneca encouraged women to have yearly mammograms. ... 
Read More


Roche's Perjeta is helping Breast Cancer Patients Live Longer
According to newly released results at the European Society for Medical Oncology, Roche's Perjeta's is lengthening the life expectancy of patients with HER2-positive breast cancer ... 
Read More


2015 Will Bring Changes for J&J Pension Benefits
In an effort to cut costs, J&J has announced that starting January 1, 2015 the company will reduce the pension benefits it offers to newly ... 
Read More


Release of generic form of Nexium is delayed
With sales of AstraZeneca's Nexium bringing in over $2 billion in US sales last year, there are several generics makers who are ready to enter ... 
Read More


Questions about Biosimilars
Recent inquires to the FDA have raised more questions about whether biosimilars should keep the same name as the branded biotech drugs. Doctor's state if ... 
Read More


Plans for a Future Biotech Hub in New York
Pfizer, Eli Lilly and J&J have each contributed to a $51 million fund which will lay the groundwork the creation of a biotech hub on ... 
Read More


High Price for Gilead’s Hepatitis C Treatment
Gilead's new hepatitis C treatment Savaldi came on the market in December. At that time, patients were receiving approval for the $84,000 treatment. Fast forward ... 
Read More


Projected Top 10 Brands in 2020
With over $76 billion dollars in sales, 2013 was a good year for the best-selling drugs. According to EvaluatePharms'a annual world preview report, the top ... 
Read More


AbbVie Continues its Quest for Shire
After three failed attempts, AbbVie has put together a $51.5 billion dollar deal to acquire Shire.  AbbVie would like to expand on its top selling ... 
Read More


Cubist Receives FDA Approval
Cubist has received FDA approval for Sivextro, an antibacterial drug it acquired after buying Trius about a year ago. This drug can be used to ... 
Read More


« prev - page 1 of 2 - next »